Demonstration of the Medical Interest of the VisioCyt® Artificial Intelligence Test

Inclusion Criteria: * Age ≥18 years old and autonomous * Patient understanding national language well and able to understand the protocol. * Patient information and informed consent signature before the start of the study * Patients under surveillance of Non-muscle invasive bladder cancer (NMIBC) at high and very high risk of progression, whatever the stage on the basis of a histological result. The diagnosis (primary or recurrence) should be less than or equal to 24 months (the last histology result confirming a bladder cancer with high or very high risk of recurrence is taken into account). Exclusion Criteria: * Patients who have had total bladder resection or bladder reconstruction * Age \<18 years old * Person deprived of liberty or under guardianship (including curatorship) * Bladder cancer outside of urothelial carcinoma * Associated high urinary tract carcinoma * Kidney transplant patient (BK virus) * Pelvic radiotherapy patient (prostate cancer) * Patients with or under surveillance of a muscle-infiltrating bladder tumor